LTGOLatigo Biotherapeutics Inc.
+4.1% today
No score: too little data.
No dividend.
Latigo Biotherapeutics Inc. (LTGO) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €942.7M.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Red flags and notes
- Negative equity Book equity is below zero.
- Short history Less than one year of prices: not ranked yet.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- Market cap (EUR)
- €942.7M
Dividends
- Dividend yield
- 0.00%
- Years of dividend growth
- 0
Returns and risk
- 1 day
- +4.1%
- 1 month
- −9.4%
- Max drawdown, 1 yr
- −44.0%
Returns are price changes from end-of-day prices, without dividends.
Similar companies
Same sector and region, closest in market value.
| MLTXMoonLake Immunotherapeutics | 1/10 | 0.0% | 25.4% |
|---|---|---|---|
| CBLLCeriBell Inc. | 2/10 | 0.0% | 112.2% |
| BVSBioventus Inc. | 9/10 | 0.0% | 111.1% |
| IRMDiRadimed Corporation | 7/10 | 0.9% | 6.6% |
| INBXInhibrx Biosciences Inc. | —/10 | 0.0% | 7.0% |
| RAPPRapport Therapeutics Inc. | 1/10 | 0.0% | −22.3% |
| HROWHarrow Inc. | 2/10 | 0.0% | −23.0% |
| MNKDMannKind Corporation | 1/10 | 0.0% | −35.3% |
News and filings
- Latigo Biotherapeutics, Inc.: 10-Q — Quarterly report for the period ending 30 Jun 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 3 Sep 2026
- Latigo Biotherapeutics, Inc.: 8-K — Results of operations
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 3 Sep 2026
- Latigo Biotherapeutics, Inc.: 8-K — Charter or bylaw amendment; other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 10 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
No published ratings in the last 12 months.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.